Literature DB >> 28077742

Colonization Factors in Enterotoxigenic Escherichia coli Strains in Travelers to Mexico, Guatemala, and India Compared with Children in Houston, Texas.

Vineetkumar B Kharat1, Makhdum Ahmed1, Zhi-Dong Jiang2, Mark S Riddle3, Herbert L DuPont1,4.   

Abstract

Enterotoxigenic Escherichia coli (ETEC) can be attributed to around 200 million diarrheal episodes and 380,000 deaths in the developing regions. Travelers' diarrhea occurs in 15-40% of travelers to developing regions with ETEC being the most important etiologic agent. This study aims to describe the distribution of enterotoxins and colonization factor (CF) profiles of ETEC isolates from stool samples of adult travelers acquiring diarrhea in Mexico, Guatemala, and India and a group of children with acute diarrhea in Houston, TX, between 2007 and 2012. The heat-labile/heat-stable (LT/ST) enterotoxins and CFs from 252 patients were determined using polymerase chain reaction assay. Among the 252 ETEC isolates, 15% were LT-only, 58% were ST-only, and 28% produced both LT and ST. The distribution of LT-only (12-15%) and ST-only (55-56%) isolates was similar between Latin American and Indian sites. The most prevalent CF was CS21, expressed in 65% of the isolates followed by CS6 (25%) and CS3 (17%). Among the international travelers, 64% of the ETEC isolates expressed CS21. CS21 was expressed in 46% of isolates from Latin America compared with 96% of isolates from India (P < 0.0001). CS21 was expressed in 85% isolates from Houston children. CS21 was increasingly found in ST-only (P = 0.003) and ST/LT (P = 0.026) ETEC compared with LT-only ETEC. High frequency of finding CS21 among recent isolates of ETEC over a wide geographic distribution warrants additional studies on this CF. Highly conserved CS21 is an important target for potential multivalent ETEC vaccines. © The American Society of Tropical Medicine and Hygiene.

Entities:  

Mesh:

Year:  2016        PMID: 28077742      PMCID: PMC5239714          DOI: 10.4269/ajtmh.16-0405

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  32 in total

1.  Enterotoxigenic Escherichia coli CS21 pilus contributes to adhesion to intestinal cells and to pathogenesis under in vivo conditions.

Authors:  C P Guevara; W B Luiz; A Sierra; C Cruz; F Qadri; R S Kaushik; L C S Ferreira; O G Gómez-Duarte
Journal:  Microbiology       Date:  2013-06-12       Impact factor: 2.777

2.  Status of vaccine research and development for enterotoxigenic Escherichia coli.

Authors:  A Louis Bourgeois; Thomas F Wierzba; Richard I Walker
Journal:  Vaccine       Date:  2016-03-15       Impact factor: 3.641

Review 3.  Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention.

Authors:  Firdausi Qadri; Ann-Mari Svennerholm; A S G Faruque; R Bradley Sack
Journal:  Clin Microbiol Rev       Date:  2005-07       Impact factor: 26.132

4.  The oral, live attenuated enterotoxigenic Escherichia coli vaccine ACE527 reduces the incidence and severity of diarrhea in a human challenge model of diarrheal disease.

Authors:  Michael J Darsley; Subhra Chakraborty; Barbara DeNearing; David A Sack; Andrea Feller; Charlotte Buchwaldt; A Louis Bourgeois; Richard Walker; Clayton D Harro
Journal:  Clin Vaccine Immunol       Date:  2012-10-03

5.  Protection by milk immunoglobulin concentrate against oral challenge with enterotoxigenic Escherichia coli.

Authors:  C O Tacket; G Losonsky; H Link; Y Hoang; P Guesry; H Hilpert; M M Levine
Journal:  N Engl J Med       Date:  1988-05-12       Impact factor: 91.245

6.  Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial.

Authors:  Sarah A Frech; Herbert L Dupont; A Louis Bourgeois; Robin McKenzie; Jaime Belkind-Gerson; Jose F Figueroa; Pablo C Okhuysen; Norma H Guerrero; Francisco G Martinez-Sandoval; Juan Hm Meléndez-Romero; Zhi-Dong Jiang; Edwin J Asturias; Jane Halpern; Olga R Torres; Ana S Hoffman; Christina P Villar; Raniya N Kassem; David C Flyer; Bo H Andersen; Kazem Kazempour; Sally A Breisch; Gregory M Glenn
Journal:  Lancet       Date:  2008-06-14       Impact factor: 79.321

7.  Serologic correlates of protection against enterotoxigenic Escherichia coli diarrhea.

Authors:  Malla R Rao; Thomas F Wierzba; Stephen J Savarino; Remon Abu-Elyazeed; Nemat El-Ghoreb; Eric R Hall; Abdollah Naficy; Ibrahim Abdel-Messih; Robert W Frenck; Ann-Mari Svennerholm; John D Clemens
Journal:  J Infect Dis       Date:  2005-01-14       Impact factor: 5.226

8.  Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant.

Authors:  J Holmgren; L Bourgeois; N Carlin; J Clements; B Gustafsson; A Lundgren; E Nygren; J Tobias; R Walker; A-M Svennerholm
Journal:  Vaccine       Date:  2013-03-27       Impact factor: 3.641

9.  Randomised, double-blind, safety and efficacy of a killed oral vaccine for enterotoxigenic E. Coli diarrhoea of travellers to Guatemala and Mexico.

Authors:  David A Sack; Janet Shimko; Olga Torres; August L Bourgeois; Domingo Sanchez Francia; Björn Gustafsson; Anders Kärnell; Iréne Nyquist; Ann-Mari Svennerholm
Journal:  Vaccine       Date:  2007-04-04       Impact factor: 3.641

10.  Expression of colonization factor CS5 of enterotoxigenic Escherichia coli (ETEC) is enhanced in vivo and by the bile component Na glycocholate hydrate.

Authors:  Matilda Nicklasson; Åsa Sjöling; Astrid von Mentzer; Firdausi Qadri; Ann-Mari Svennerholm
Journal:  PLoS One       Date:  2012-04-30       Impact factor: 3.240

View more
  10 in total

1.  Biochemical and Immunological Evaluation of Recombinant CS6-Derived Subunit Enterotoxigenic Escherichia coli Vaccine Candidates.

Authors:  Steven T Poole; Milton Maciel; Premkumar Dinadayala; Kathleen E Dori; Annette L McVeigh; Yang Liu; Eileen Barry; Christen Grassel; Michael G Prouty; Geneviève Renauld-Mongénie; Stephen J Savarino
Journal:  Infect Immun       Date:  2019-02-21       Impact factor: 3.441

2.  Coinfection with Enteric Pathogens in East African Children with Acute Gastroenteritis-Associations and Interpretations.

Authors:  Maria Andersson; Jean-Claude Kabayiza; Kristina Elfving; Staffan Nilsson; Mwinyi I Msellem; Andreas Mårtensson; Anders Björkman; Tomas Bergström; Magnus Lindh
Journal:  Am J Trop Med Hyg       Date:  2018-04-19       Impact factor: 2.345

Review 3.  Heat-Stable Enterotoxins of Enterotoxigenic Escherichia coli and Their Impact on Host Immunity.

Authors:  Haixiu Wang; Zifu Zhong; Yu Luo; Eric Cox; Bert Devriendt
Journal:  Toxins (Basel)       Date:  2019-01-08       Impact factor: 4.546

4.  The Coli Surface Antigen CS3 of Enterotoxigenic Escherichia coli Is Differentially Regulated by H-NS, CRP, and CpxRA Global Regulators.

Authors:  Miguel A Ares; Judith Abundes-Gallegos; Diana Rodríguez-Valverde; Leonardo G Panunzi; César Jiménez-Galicia; Ma Dolores Jarillo-Quijada; María Lilia Cedillo; Marìa D Alcántar-Curiel; Javier Torres; Jorge A Girón; Miguel A De la Cruz
Journal:  Front Microbiol       Date:  2019-07-25       Impact factor: 5.640

5.  Oral delivery of Hyperimmune bovine serum antibodies against CS6-expressing enterotoxigenic Escherichia coli as a prophylactic against diarrhea.

Authors:  K R Talaat; C K Porter; A L Bourgeois; T K Lee; C A Duplessis; M Maciel; R L Gutierrez; B DeNearing; B Adjoodani; R Adkinson; K J Testa; B Feijoo; A N Alcala; J Brubaker; A Beselman; S Chakraborty; D Sack; J Halpern; S Trop; H Wu; J Jiao; E Sullivan; M S Riddle; S S Joseph; S T Poole; M G Prouty
Journal:  Gut Microbes       Date:  2020-03-13

6.  Molecular characterization of enterotoxigenic Escherichia coli toxins and colonization factors in children under five years with acute diarrhea attending Kisii Teaching and Referral Hospital, Kenya.

Authors:  Erick Kipkirui; Margaret Koech; Abigael Ombogo; Ronald Kirera; Janet Ndonye; Nancy Kipkemoi; Mary Kirui; Cliff Philip; Amanda Roth; Alexander Flynn; Elizabeth Odundo; Janeth Kombich; Ibrahim Daud
Journal:  Trop Dis Travel Med Vaccines       Date:  2021-12-15

7.  The role of CFA/I in adherence and toxin delivery by ETEC expressing multiple colonization factors in the human enteroid model.

Authors:  Emily M Smith; Christen L Grassel; Antonia Papadimas; Jennifer Foulke-Abel; Eileen M Barry
Journal:  PLoS Negl Trop Dis       Date:  2022-07-26

8.  Intestinal Epithelial Cells Modulate the Production of Enterotoxins by Porcine Enterotoxigenic E. coli Strains.

Authors:  Haixiu Wang; Eric Cox; Bert Devriendt
Journal:  Int J Mol Sci       Date:  2022-06-13       Impact factor: 6.208

Review 9.  Colonization with extended-spectrum beta-lactamase-producing Escherichia coli and traveler's diarrhea attack rates among travelers to India: a systematic review and meta-analysis.

Authors:  Basilua Andre Muzembo; Kei Kitahara; Ayumu Ohno; Keinosuke Okamoto; Shin-Ichi Miyoshi
Journal:  Trop Dis Travel Med Vaccines       Date:  2022-10-01

10.  Impact of Rotavirus Vaccine Introduction and Postintroduction Etiology of Diarrhea Requiring Hospital Admission in Haydom, Tanzania, a Rural African Setting.

Authors:  James A Platts-Mills; Caroline Amour; Jean Gratz; Rosemary Nshama; Thomas Walongo; Buliga Mujaga; Athanasia Maro; Timothy L McMurry; Jie Liu; Estomih Mduma; Eric R Houpt
Journal:  Clin Infect Dis       Date:  2017-10-01       Impact factor: 9.079

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.